about
Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin AUnusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strainsPromoter of FGF8 reveals a unique regulation by unliganded RARalphaPhylogenetic approach reveals that virus genotype largely determines HIV set-point viral loadAssessing predicted HIV-1 replicative capacity in a clinical settingLong-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimensAdherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort StudyThe individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patientsPersistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgroundsCorrection: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing RegimensMinor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patientsHigh specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of diseaseParent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup.Estimating the basic reproductive number from viral sequence data.Library-based discovery and characterization of daphnane diterpenes as potent and selective HIV inhibitors in Daphne gnidium.Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.Inferring epidemic contact structure from phylogenetic trees.Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.A sensitive replicative system to assess HIV-1 drug resistance.Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide.Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.A diagnostic HIV-1 tropism system based on sequence relatedness.Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFNβ-therapy.Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study.Development of a simple microarray for genotyping HIV-1 drug resistance mutations in the reverse transcriptase gene in rural Tanzania.Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based AlgorithmsAlcohol use and depression: link with adherence and viral suppression in adult patients on antiretroviral therapy in rural Lesotho, Southern Africa: a cross-sectional study.Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1A Case Series of Acquired Drug Resistance-Associated Mutations in Human Immunodeficiency Virus-Infected Children: An Emerging Public Health Concern in Rural Africa.Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in SwitzerlandPrevalence of drug resistance mutations and HIV type 1 subtypes in an HIV type 1-infected cohort in rural TanzaniaTracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairsA genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland.Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern.The XTrack system: application and advantage.
P50
Q24563176-46CDCEA5-6CAC-4BC2-B2BD-8BB092A485AFQ27640076-12DB6415-8164-46AE-9DDD-43C72879366CQ28203481-5BCD220A-60E3-4015-9184-C272E8CC15D2Q28475652-CFFE7D8E-74C2-4280-8596-BCB324678CC4Q28477801-081AEFB2-145C-4557-9333-A5C60C30B634Q28485321-A17E5AFB-EE70-4DCE-A042-0A40FE73F3F6Q28534423-00FAB13C-61D4-4243-B2BD-F5A7F3A56312Q28536153-2603A86C-20A9-4516-9FA0-1DC13BB1C095Q28544845-FB3AF675-69A3-4E38-8A98-80E2CCB90FA6Q28683189-033B805C-6FFB-439B-BD33-9C022BD2EFCDQ28728304-0AB75FAC-B772-435E-B2CD-F406B3F1821DQ28744063-8CF195FD-0525-45CB-9457-64108C0B1F36Q33722738-7A8D0894-AB4C-49DB-8A29-9C747CBB83DEQ34010717-C72AD5AF-25E5-4EC5-A7FA-BBDB440B2C2DQ34093364-A5063131-D2F0-481E-91AE-7DE77C903E57Q34109639-3C43ECFC-1C4F-4333-9E60-7D6EA1622128Q34192802-05756EED-0A8A-4B27-827F-9AD714F5A54EQ34231138-9CF509EC-D83D-42A4-A23F-D113F00AE1E8Q34400923-F63ED1EB-05B9-489D-B0E3-338A49877768Q34547116-A3E3A86F-9A29-4AF3-BC3B-C024BEBD8D5FQ34613799-E95E13D3-F496-4BA6-AFDF-33C50C69D9D3Q34662575-DFC66A94-28DC-4083-997E-4876C9A9587AQ34699175-196B5305-4FF6-41F7-B970-D25D09C2F8FFQ34976999-E6EB8D03-B16B-47B8-9FB8-840903F1109EQ34983107-C6AD79BF-C920-4F05-AB8A-2887655537E8Q35040965-F25724A2-2118-4B51-87A9-CACBFB5EBCFBQ35057734-4EC0BBB4-4968-4796-AFEE-2614CF4371C2Q35127150-20AD5EA0-5EA8-4F9B-A80E-23C3FB521514Q35729544-D2E7FCEF-3242-4529-BDAA-2B033398485FQ36127177-E7463F91-B89D-4296-BC0F-F3B06FF97DCFQ36186007-E0E2650E-DE76-496E-8D79-E6ED03E84042Q36419489-2822E2E3-310F-43C7-9EB3-48D557680560Q36488965-DAA12A86-1A11-44F6-AB19-FF217D916E2CQ37000515-081F3AC9-E0B4-4582-AE3F-E098EAAE6710Q37111546-DBAC5F81-98FA-43D8-8842-B05BB0EF3942Q37233074-ED18DC4E-5BD2-4BEF-AB34-9E607DDBFDE5Q37254045-AD22333F-2DED-49FF-B718-5DDD738F79ECQ37264576-26B07318-2E5A-4B40-91F6-44535BA9CC8DQ37461250-68F96003-9572-4DDE-B587-7CA1E46A1A0BQ37979701-1F1C55AC-FB34-455A-AB0F-9F3AFAEADA8C
P50
name
Thomas Klimkait
@ast
Thomas Klimkait
@en
Thomas Klimkait
@nl
type
label
Thomas Klimkait
@ast
Thomas Klimkait
@en
Thomas Klimkait
@nl
prefLabel
Thomas Klimkait
@ast
Thomas Klimkait
@en
Thomas Klimkait
@nl